genom
studi
structur
function
deoxyribonucl
acid
dna
within
gene
genom
context
branch
genet
less
focus
downstream
product
studi
proteomicsor
correl
specif
hered
trait
clinic
genet
use
genomewid
associ
studi
gwa
wholegenom
sequenc
wg
approach
investig
molecular
structur
haplotyp
variat
geneenviron
complex
affect
genotyp
phenotyp
invok
life
scienc
system
studi
omic
gwa
captur
populationwid
pictur
health
look
locat
pattern
across
multipl
gene
mani
peopl
thu
genom
refocus
individu
diagnost
alli
servic
initi
identifi
opportun
improv
health
transform
healthcar
across
popul
church
genom
medicin
quantit
differ
genet
use
variant
marker
diagnosi
prognosi
prevent
well
target
treatment
variant
segreg
nonmendelian
well
mendelian
pattern
integr
evid
base
geneenviron
interact
public
health
genom
extend
studi
populationwid
variat
impact
evidencebas
polici
health
system
health
deliveri
resourc
concurr
sequenc
technolog
develop
largescal
gener
popul
data
use
informat
collect
store
analyz
genet
combin
pattern
network
human
genom
project
hgp
landmark
genom
intern
consortium
effort
map
entir
human
genom
start
complet
public
human
refer
genom
herald
genom
era
collin
et
al
character
highthroughput
sequenc
highresolut
data
largescal
bioinformat
hgp
mileston
signific
develop
efficaci
econom
sequenc
tool
avail
research
lend
studi
popul
variant
within
exom
complet
hgp
futur
genom
set
three
grand
challeng
collin
et
al
genom
biolog
elucid
structur
function
genom
genom
health
translat
genomebas
knowledg
health
benefit
genom
societi
promot
use
genom
maxim
benefit
minim
harm
mani
challeng
alreadi
met
though
applic
everyday
sequenc
effici
accur
analyt
human
genom
sequenc
error
hour
less
us
goal
genom
sequenc
access
us
clinic
purpos
would
extrem
low
error
rate
comprehens
relev
variat
among
gene
exom
haplotyp
term
public
health
implic
genom
substanti
extend
preand
neonat
screen
predisposit
suscept
complex
disord
transform
healthcar
servic
organ
deliveri
creation
vast
amount
data
simultan
requir
complex
system
storag
access
analyt
creat
new
paradigm
popul
health
care
prevent
treatment
genom
drive
concurr
technolog
commerci
public
biobank
initi
open
access
databas
like
genom
project
see
relev
websit
list
end
articl
commerci
person
medicin
contribut
context
big
data
data
acquisit
use
scale
allow
new
insight
creat
new
form
valu
applic
genom
mani
area
public
health
expand
studi
emerg
infecti
diseas
spread
evolv
inform
futur
pandem
plan
technolog
advanc
signific
ethic
legal
social
implic
elsi
elsi
built
hgp
parallel
integr
research
program
anticip
identifi
develop
strategi
respect
creation
implement
vast
data
set
inform
would
gener
implic
expand
signific
individualin
term
concept
like
consent
privacyto
societ
impact
govern
genom
infrastructur
use
access
technolog
health
system
committe
evalu
elsi
program
human
genom
project
appoint
assess
issu
rais
consequ
hgp
longer
term
rais
gener
research
involv
human
genet
follow
dynam
period
public
debat
scholarli
work
polici
make
enact
nation
legisl
genet
inform
nondiscrimin
act
unit
state
elsi
initi
soon
becam
appli
bioethic
approach
concern
new
develop
diagnosi
treatment
human
diseas
possibl
reproduct
choic
becam
character
ethic
legal
social
scrutini
implic
emerg
technolog
activ
outreach
constitu
involv
develop
use
make
issu
relev
polici
maker
access
public
particular
elsi
focus
design
conduct
genom
research
respect
product
analysi
share
individu
genom
inform
rapid
advanc
genom
technolog
avail
increas
amount
genom
inform
affect
health
care
develop
new
paradigm
regulatori
approach
clinic
medicin
public
health
europ
ethic
legal
social
aspect
elsa
scienc
strengthen
contribut
field
philosophi
scienc
technolog
studi
sociolog
respect
genom
technolog
govern
sinc
hgp
consortium
develop
intern
hapmap
projecta
catalog
common
genet
variant
see
relev
websit
concurr
effort
extend
analysi
implic
genom
societi
exampl
launch
elsi
would
catalyz
intern
collaboratori
ethic
scienc
polici
analyz
grand
challeng
genom
though
global
initi
develop
digit
tool
protocol
infrastructur
kay
et
al
human
genom
organ
hugo
committe
ethic
law
societi
publish
number
statement
includ
propos
benefitshar
model
respect
common
human
human
genom
hugo
next
gener
highthroughput
comprehens
sequenc
technolog
becom
integr
featur
futur
clinic
decis
make
genom
sequenc
like
target
genet
test
may
carri
individu
level
clinic
medicin
genet
test
avail
hand
gene
chromosom
variant
known
caus
associ
particular
diseas
test
highli
predict
penetr
carrier
statu
clinic
genom
sequenc
rais
challeng
uniqu
differ
scope
first
systemat
sequenc
entir
genom
clinic
correl
addit
reveal
specif
gene
involv
multilevel
analysi
complex
common
disord
variant
indic
probabl
rather
diagnosi
multifactori
diseas
like
type
ii
diabet
heart
diseas
clinic
genom
correl
common
disord
evalu
suscept
predisposit
often
creat
openend
diagnos
differ
current
use
genet
test
case
prognosi
uncertain
treatment
pathophysiolog
state
might
avail
often
lifestyl
chang
might
way
manag
avoid
onset
etiolog
secondli
gene
discoveri
go
like
normal
test
base
inform
counsel
incident
nontarget
find
might
unwant
unexpect
presenc
carrier
gene
presymptomat
allel
lack
effect
treatment
nonmed
inform
patern
therefor
way
manag
counsel
patient
anticip
thirdli
sequenc
entir
genom
reveal
mani
find
potenti
data
might
use
across
one
life
span
genom
sequenc
queri
repeatedli
novel
gene
implic
diseas
new
gene
target
identifi
clinic
use
diagnost
becom
possibl
instead
need
test
time
might
life
time
read
clinic
inform
laid
full
inform
publish
one
go
list
condit
diseas
predisposit
risk
might
design
ad
hoc
inquiriesth
physician
go
back
sequenc
databas
submit
queri
base
present
clinic
present
data
instal
within
person
genom
chip
carri
one
person
ident
document
passport
locat
health
repositori
cover
mani
peopl
readili
access
challeng
would
model
cost
effect
popul
levelsystem
might
permit
multifactori
analysi
mani
marker
simultan
given
profil
access
would
request
indic
present
symptom
physician
call
relev
inform
would
take
advantag
develop
provid
expedi
health
commun
patient
see
section
big
data
fourthli
commun
health
implic
remain
complex
involv
interpret
risk
environment
factor
predict
etiolog
diseas
progress
two
implic
one
understand
postnat
adult
exposur
agent
affect
gene
expressionso
whether
fact
trait
revers
malleabl
two
whether
populationbas
studi
risk
underestim
potenti
import
particular
develop
event
individu
individu
experi
exposur
environ
factor
differ
way
difficult
meaning
measur
part
public
health
assumpt
gener
may
skew
public
health
react
popul
event
differ
event
impact
individu
howev
mani
ethic
issu
similar
clinic
genet
regard
continu
shortcom
clinic
educ
genom
uneasi
interpret
clinic
correl
patient
lack
infrastructur
support
sequenc
data
storag
access
genom
medicin
larg
interpret
lifestyl
environ
clinic
correl
genom
effect
respect
health
factor
treatment
option
outcom
mean
lifestyl
choic
environ
becom
import
target
polici
prevent
health
promot
therefor
highli
relev
public
health
scale
individu
health
suscept
effect
populationwid
social
determin
health
ignit
interest
largescal
popul
resourc
biobank
meet
demand
inform
resourc
adapt
clinic
queri
novel
drug
technolog
intervent
target
genom
polymorph
centr
diseas
control
prevent
offic
public
health
genom
maintain
onlin
databas
genom
test
potenti
impact
public
health
call
genom
applic
practic
prevent
gapp
see
relev
websit
includ
genom
target
treatment
risk
predict
prognosi
subtyp
diagnost
aid
clinic
use
respect
ethic
implic
clinic
medicin
popul
effect
felt
reproduct
health
genom
creat
opportun
prospect
parent
rais
question
respect
broadband
screen
test
embryo
fetus
neonat
exampl
mani
test
concurr
offer
simultan
analyz
test
may
analog
indirect
screen
offer
pregnanc
instanc
recommend
potenti
invas
test
rais
issu
respect
option
parent
knowledg
variant
correl
percept
disabl
beyond
wg
reveal
mani
potenti
target
screeningthi
rais
question
expans
registri
permit
diseas
previous
base
wilson
junger
criteria
see
read
one
implic
famili
cultur
also
reveal
complex
health
inform
genegen
genomeenviron
interact
public
health
applic
also
includ
sequenc
pathogen
see
follow
section
cancer
genom
allow
target
treatment
effect
present
fewer
sideeffect
individu
would
scale
stratifi
treatment
popul
number
consortium
map
genom
respect
specif
diseas
variat
exampl
cancer
genom
atla
tcga
project
nation
cancer
institut
set
compil
genom
common
cancer
unit
kingdom
breast
cancer
somat
genet
studi
creat
genom
profil
breast
cancer
case
see
relev
websit
list
end
articl
translat
genomebas
knowledg
technolog
improv
popul
health
signific
implic
health
system
impact
deliveri
health
care
popul
genom
clinic
util
depend
part
develop
analyt
read
expedi
errorfre
vast
complex
genotyp
done
differ
stage
embryo
prior
implant
prenat
neonat
screen
diagnost
upon
clinic
present
requir
invest
data
storag
system
handl
larg
amount
inform
algorithm
simultan
process
synthes
interpret
interact
biolog
environment
variabl
creat
statist
associ
specif
gene
sequenc
pattern
realiz
genom
medicin
anxieti
elsi
genet
like
reemerg
public
discours
term
public
health
genom
organ
effort
social
chang
becom
alli
posit
reaction
environment
determin
health
sens
gene
effect
often
determinist
identif
function
character
concept
like
risk
suscept
critic
predict
health
outcom
applic
pollut
toxic
exposur
popul
stratif
eg
respect
poverti
drug
use
theme
well
healthi
otherwis
lifestyl
reemerg
genet
determin
essenti
featur
earli
genet
explain
simpl
complex
behavior
way
gene
less
like
given
acknowledg
epigenet
environment
effect
known
occur
throughout
embryon
develop
postnat
life
howev
genetic
ongo
process
differ
individu
reduc
deoxyribonucl
acid
dna
code
lippman
may
becom
persuas
medic
practic
way
genom
shape
medicin
societi
cultur
genom
engag
societi
might
lead
counterproduct
way
diagnosi
prognosi
treatment
also
social
profession
attitud
reflect
unpack
health
determin
especi
concurr
shift
high
penetr
test
less
certain
genom
context
exampl
kind
prosaic
attitud
may
contribut
increas
medic
health
use
explan
genom
focu
ill
result
genom
fate
unavoid
choic
blameworthi
appli
across
popul
perhap
impercept
medicosoci
chang
may
signific
implic
public
health
effort
health
expenditur
alloc
poverti
allevi
environment
activ
one
key
ethic
challeng
provid
appropri
balanc
prevent
untim
translat
nonvalid
potenti
harm
technolog
practic
lose
sight
benefit
genom
technolog
appropri
use
burk
et
al
person
genom
medicin
use
inform
gene
interact
protein
environ
prevent
diagnos
treat
diseas
individu
level
knowledg
gene
variant
potenti
allow
individu
respons
therefor
effect
clinic
treatment
might
avoid
unnecessari
hazard
health
care
particularli
avert
advers
drug
reaction
util
reliabl
variat
allow
physician
prescrib
effectivelyavoid
potenti
ineffect
andor
expens
medicationsand
allow
individu
make
inform
decis
manag
lifestyl
avoid
potenti
environment
trigger
pharmacogenom
studi
gene
affect
person
respons
drug
may
use
stratifi
popul
accord
recommend
treatment
exampl
herceptin
therapeut
antibodi
design
treatment
metastat
breast
cancer
shown
highli
effect
tumor
copi
gene
ineffect
neg
gene
ross
et
al
approach
might
expand
screen
popul
effect
specif
cancer
better
target
less
harm
econom
drug
manag
exampl
popul
stratif
use
isosorbid
hydralazin
fixeddos
combin
bidil
provok
controversi
approv
food
drug
administr
first
drug
market
singl
group
african
american
treatment
congest
heart
failur
brodi
hunt
mani
cultur
group
relationship
character
ancestri
sometim
relat
social
background
cultur
associ
addit
observ
custom
tradit
commun
share
certain
trait
may
permeat
gener
alway
isol
close
hereditari
relat
one
ancestri
certain
social
ident
impli
certain
right
oblig
knowledg
genom
may
break
hereditari
lineag
closeknit
commun
may
weari
debunk
hereditari
belief
moreov
may
object
certain
kind
researchparticularli
delv
trait
behavior
signific
social
repercuss
mello
wolf
howev
also
clear
gene
predetermin
kind
ident
beyond
import
famili
bond
develop
close
relationship
partnership
friendship
adopt
case
stress
challeng
hered
social
bond
uniformli
subject
equal
like
offer
explan
mani
share
social
valu
behavior
characterist
health
trait
misus
perpetu
genom
character
mere
keep
aliv
prejudic
serv
excus
noth
exist
social
inequ
current
model
person
medicin
larg
develop
directtoconsum
product
combin
commerci
enterpris
clinic
care
provis
model
challeng
respect
opaqu
protocol
consent
data
manag
concern
relat
interpret
test
result
absenc
inappropri
system
disclosur
clinic
result
custom
exampl
investig
us
govern
account
offic
conclud
test
result
often
mislead
littl
practic
use
gao
industri
accus
offer
medic
advic
without
appropri
clinic
licens
often
oper
outsid
medic
regulatori
oversight
particular
concern
consum
access
genet
counsel
util
commerci
servic
futur
person
genom
medicin
bound
current
limit
speed
cost
map
singl
genom
make
clinic
use
preclus
given
quick
accur
rel
afford
sequenc
becom
realiti
person
medic
data
may
merg
public
data
system
purpos
public
health
plan
environment
pathogen
surveil
diseas
respons
research
allud
popul
stratif
respect
medic
mani
strategi
care
mention
face
logist
challeng
obtain
suitabl
genom
inform
time
enough
fashion
guid
diagnosi
prescript
includ
drug
lifestyl
modif
deliv
broadli
enough
cover
popul
place
genom
inform
electron
medic
record
cover
citizen
would
facilit
kind
person
medicin
patient
entir
genom
part
medic
record
complex
acquir
dna
sampl
ship
sequenc
laboratori
wait
readout
would
replac
electron
queri
data
inquiri
would
still
need
clinic
interpret
howev
safeguard
necessari
maintain
integr
model
includ
challeng
access
control
data
medium
repositori
accuraci
longterm
stabil
data
clinic
rigor
analysi
interpret
like
number
ongo
debat
applic
clinic
genet
reemerg
conceptu
target
screeningwher
predisposit
risk
traitto
applic
direct
test
haploor
phenotyp
current
clinic
genet
offer
patient
receiv
preand
posttest
genet
counsel
clinic
genom
would
like
requir
substanti
infrastructur
review
provid
coverag
popul
access
offer
clinic
staff
also
util
commerci
genom
sequenc
larg
burden
interpret
sequenc
would
like
fall
primari
physician
expand
repertoir
routin
laboratori
test
real
time
scrutini
patient
electron
health
genom
record
report
uk
human
genom
strategi
group
includ
recommend
improv
genom
train
healthcar
profession
chang
medic
educ
meet
futur
need
human
genom
strategi
group
number
variat
across
possibl
sequenc
genom
go
ten
million
rais
signific
issu
big
data
big
data
concept
concern
data
larg
size
typic
extent
manipul
manag
present
signific
logist
challeng
signifi
thing
one
larg
scale
done
smaller
one
extract
new
insight
creat
new
form
valu
cukier
big
data
becom
key
compon
crime
control
social
engin
diseas
predict
infecti
diseas
emerg
spread
genom
therefor
version
big
data
perspect
size
applic
like
sourc
big
data
becom
driver
health
inform
invest
big
data
associ
cultur
open
access
open
consent
altruism
opportun
collect
vast
amount
inform
peopl
embrac
genom
medic
record
part
vast
network
camera
drone
person
track
eg
face
recognit
softwar
transport
card
credit
card
librari
card
map
habit
purchas
holiday
interest
inform
analyt
internet
use
allencompass
data
creation
rais
question
ownership
use
inform
gener
populationwid
health
system
also
divers
intellig
gather
logist
sourc
exampl
unit
kingdom
govern
caredata
initi
propos
sale
research
institut
pharmaceut
corpor
other
data
visit
nation
health
servic
clinician
seen
resourc
benefit
collat
vast
data
make
avail
research
mine
uk
report
observ
although
busi
govern
unit
belief
potenti
big
data
drive
econom
growth
scientif
innov
servic
effici
number
potenti
less
welcom
implic
right
privaci
sciencewis
exampl
sale
health
data
concern
patient
explicitli
agre
share
impli
intrus
new
commerci
goal
diverg
origin
consent
provid
cours
clinic
care
sometim
compound
barrier
opt
commerci
enterpris
one
hand
presuppos
collect
interest
econom
social
public
health
benefit
justifi
overrid
principl
protect
individu
often
captur
consent
privaci
norm
hand
well
violat
right
betray
doctorpati
relationship
argu
assumpt
especi
link
commerci
diminish
public
support
critchley
recent
special
edit
scienc
lament
end
privaci
along
chang
attitud
make
one
genet
sequenc
avail
public
experiment
confirm
knowhow
possibl
identifi
person
close
databas
open
genealog
internet
searcher
gymrek
et
al
signific
challeng
tradit
research
clinic
ethic
big
data
enabl
emerg
opportun
genom
one
volunt
unawar
provid
data
case
particip
open
data
patient
creat
novel
question
privaci
consent
particip
dynam
norm
clinic
relationship
within
network
big
data
collector
user
gener
suggest
patientspecif
inform
includ
central
databasescruci
longterm
success
genom
medicineth
harder
ensur
patient
anonym
compel
case
yet
made
big
data
contribut
public
health
research
still
question
capac
store
analyz
data
use
problem
theori
free
method
statist
game
valid
infer
made
vast
correl
although
also
case
fuzzi
big
data
among
other
eg
format
inconsist
measur
artifact
result
represent
messi
realiti
global
data
rapid
evolut
technolog
googl
flu
attempt
predict
influenza
activ
shown
flaw
predat
influenza
pandem
question
use
nation
global
epidemiolog
surveil
network
growth
emphasi
creat
big
data
challeng
ethic
within
inform
stream
link
studi
across
comput
around
globe
concern
howev
detract
use
tool
care
construct
data
set
provid
health
research
biobank
featur
public
health
research
time
character
data
therein
health
record
andor
lifestyl
inform
biolog
sampl
variou
popul
design
enabl
potenti
vast
clinic
correl
biobank
govern
model
control
kind
access
use
data
possibl
capp
public
health
might
affect
use
clinic
research
context
addit
genet
research
includ
cord
blood
bank
bank
storag
gamet
embryo
use
ivf
stem
cell
bank
biobank
rais
specif
issu
respect
whether
necessari
consent
data
appropri
research
purpos
acquisit
data
becom
acut
locat
central
databas
cover
mani
thousand
peopl
may
want
particip
exampl
recent
decod
genet
icelandbas
compani
determin
sequenc
whole
genom
iceland
imput
variant
found
rest
popul
via
genotyp
individu
pedigre
iceland
peopl
gudbjartsson
et
al
claim
genotyp
brcapredispos
breast
cancer
could
infer
across
popul
editori
accompani
natur
special
edit
genom
iceland
state
result
could
provid
strategi
analysi
genet
variat
popul
rais
question
societi
implement
knowledg
gain
see
relev
websit
end
articl
decod
exampl
contenti
regard
although
collect
full
dna
sequenc
thousand
volunt
possibl
extrapol
genotyp
featur
iceland
includ
never
volunt
present
public
health
interest
possibl
detect
mutat
volunt
popul
infer
statu
rest
popul
exampl
inform
statu
breast
cancer
eg
brca
gene
alreadi
known
question
whether
everyon
affect
told
idea
nonvolunt
might
compel
know
statu
uk
biobank
repres
differ
model
public
health
infrastructur
creat
support
divers
rang
research
intend
improv
provis
diagnosi
treatment
ill
promot
health
throughout
societi
see
relev
websit
end
articl
govern
framework
creat
mandat
public
health
allow
access
research
will
give
right
exclus
data
creat
result
provid
back
biobank
research
use
govern
framework
primarili
creat
condit
access
use
base
biobank
purpos
public
good
exampl
biobank
would
oper
stewardship
model
retain
ownership
right
resourc
avail
approv
research
time
facilit
develop
clinic
advanc
eg
diagnost
treatment
aris
use
addit
public
good
creat
sui
generi
oblig
honor
condit
donor
consent
wide
constru
accommod
public
health
mandat
signific
growth
biobank
import
defin
resourc
facilit
respons
effect
translat
genomebas
knowledg
technolog
benefit
popul
health
one
endeavor
end
biobank
biomolecular
resourc
research
infrastructur
consortiumeuropean
research
infrastructur
consortium
bbmrieric
see
relev
websit
end
articl
establish
paneuropean
research
infrastructur
biobank
biomolecular
resourc
primari
goal
initi
collabor
biobank
enabl
exchang
biolog
sampl
data
addit
establish
elsi
framework
crossbord
exchang
human
biolog
resourc
data
attach
research
use
also
establish
bbmrilarg
prospect
cohort
includ
consider
wg
respect
facilit
access
larg
prospect
studi
set
human
health
diseas
gene
patent
forc
patent
direct
human
disput
much
human
genom
alreadi
patent
one
paper
conclud
patent
claim
human
gene
base
long
nucleotid
fragment
wherea
short
fragment
nonspecif
meant
human
gene
portion
patent
rosenfeld
mason
outset
hgp
propos
dna
sequenc
gener
freeli
avail
public
principl
codifi
bermuda
principl
call
rapid
share
without
restrict
use
howev
isol
genom
sequenc
still
patent
mani
jurisdict
often
long
patent
meet
certain
condit
patent
base
outlay
research
cost
bring
invent
market
award
base
gener
principl
novelti
technic
progress
creativ
effort
invent
step
influenc
prior
patent
applic
valid
scope
descript
claim
interpret
principl
differ
jurisdict
howev
respect
dna
like
cost
identifi
function
gene
fraction
cost
turn
someth
use
make
genom
data
freeli
access
would
therefor
allow
research
focu
patent
innov
come
nevertheless
gene
patent
becom
central
mani
genom
compani
strategi
june
us
suprem
court
associ
molecular
patholog
v
myriad
genet
inc
held
natur
occur
dna
segment
product
natur
patent
elig
mere
isol
similar
judgment
subsequ
made
australia
howev
us
court
find
cdna
synthet
dna
molecul
contain
exon
involv
invent
step
thu
remain
patent
elig
clear
decis
affect
claim
sequenc
whether
still
valid
myriad
decis
substanti
concern
order
offer
whole
genom
sequenc
clinic
laboratori
would
pay
royalti
long
list
gene
patent
holder
human
genom
organ
hugo
taken
lead
advoc
benefit
share
way
realiz
genom
opportun
elabor
benefit
good
contribut
wellb
individu
andor
given
commun
thu
benefit
ident
profit
monetari
econom
sens
determin
benefit
depend
need
valu
prioriti
cultur
expect
hugo
ethic
committe
recommend
human
share
access
benefit
genet
research
hugo
benefit
share
suggest
genom
research
must
preced
engag
commun
rather
allow
exclus
interest
run
roughshod
becom
divis
howev
often
difficult
pronounc
whether
arrang
potenti
contribut
perpetu
inequ
point
context
properti
human
cell
tissu
research
exploit
often
lead
one
side
reward
grossli
disproport
littl
fair
opportun
dickenson
balanc
sought
hugo
deni
reward
artiest
scienc
bring
limit
brazenli
trawl
ring
fenc
good
make
research
possibl
biotech
compani
engag
research
popul
secur
disproportion
monopoli
accus
inequit
profit
exploit
hunt
isol
region
world
uniqu
island
popul
clamber
valuabl
biodivers
peopl
fauna
flora
critic
lack
respect
cultur
tradit
ecolog
sustain
take
profit
someth
cannotor
least
notown
sometim
character
biopir
rather
bioprospector
thu
attempt
redress
balanc
cultiv
sens
awe
global
genom
heritag
simultan
assert
behalf
commun
right
compens
particip
fair
agreement
captur
idea
genom
solidar
one
pillar
ethic
genom
research
along
benefit
share
solidar
recogn
coextens
commit
share
expect
health
econom
benefit
come
idea
condit
ethic
genom
includ
opportun
take
part
research
divest
exclus
potenti
benefit
genom
initi
equal
expect
particip
benefit
solidar
acknowledg
prize
collabor
encourag
share
imagin
address
health
challeng
new
method
call
rnaprogramm
crispr
crisprassoci
gene
ca
edit
crispr
refer
cluster
regularli
interspers
short
palindrom
repeat
referenc
system
promis
revolution
genom
doudna
charpenti
technolog
deriv
crispr
system
found
bacteria
among
function
use
defend
virus
ca
enzym
neutral
foreign
dna
snip
use
crispr
dna
sequenc
know
snip
crispr
like
person
refer
collect
acquir
resist
virus
ad
time
organ
infect
util
system
allow
research
precis
cut
dna
locat
genom
enabl
precis
control
gene
express
delet
ad
sequenc
coupl
system
read
genet
code
mechan
write
synthet
function
code
use
replac
augment
genet
diseas
tissu
insert
new
materi
alter
organ
function
situ
use
far
includ
creat
model
human
diseas
anim
introduc
environment
toler
improv
crop
yield
creat
resist
pathogen
plant
may
adapt
synthet
biolog
allow
natur
organ
reprogram
novel
use
function
make
plastic
treat
wastewat
gener
electr
manufactur
fuel
fabric
new
drug
addit
basic
scienc
enabl
might
use
target
blood
circul
parasit
virus
cancer
genom
exampl
controversi
studi
use
crispr
genet
engin
human
embryo
liang
et
al
term
public
health
crispr
rais
number
scientif
ethic
polici
issu
associ
gene
edit
experiment
level
crispr
techniqu
infal
problem
offtarget
hit
method
alter
dna
similar
site
elsewher
genom
gene
target
rais
prospect
environment
popul
damag
previous
express
spectr
genom
modifi
organ
becom
establish
control
natur
howev
technic
solv
exampl
mirror
use
termin
technolog
ensur
gmo
limit
time
wild
crispr
prospect
power
tool
creation
artifici
genom
dna
artifact
model
organ
tantal
prospect
correct
edit
point
mutat
germlin
gamet
embryo
patientderiv
tissu
impact
diseas
mendeliansingl
geneinherit
crispr
also
alter
express
multipl
gene
simultan
thu
potenti
offer
approach
complex
disord
studi
genom
potenti
lead
dual
use
technolog
exampl
sequenc
influenza
viru
potenti
introduc
threaten
characterist
moreov
concern
public
health
would
access
technolog
diybiologist
creat
synthet
modifi
organ
potenti
accident
pathogen
trait
infecti
diseas
includ
zoonot
emerg
infecti
diseas
major
health
burden
often
diseas
unpredict
pattern
emerg
transmiss
virul
attribut
part
genet
variat
genom
genom
epidemiolog
promis
understand
mechan
pathogen
exposur
infect
also
human
genet
variat
respons
diseas
includ
suscept
resist
addit
use
includ
precis
diagnosi
microbi
infect
describ
transmiss
pattern
understand
genom
emerg
drug
resist
identifi
target
new
therapeut
vaccin
genom
offer
number
tool
studi
endem
pathogen
diagnost
surveil
develop
new
synthet
drug
activ
resist
microb
respect
emerg
infecti
diseas
expedi
onsit
sequenc
fingerprint
pathogen
microb
investig
transmiss
mutat
within
commun
andor
environ
might
indic
impend
pandem
therebi
inform
appropri
respons
base
charact
pathogen
sequenc
system
place
respons
team
prepar
collect
sampl
across
globe
moment
notic
would
expedit
develop
product
pharmaceut
countermeasur
vaccin
emerg
zoonot
pathogensthos
transmit
human
animalsar
ecolog
risk
also
indic
share
suscept
speci
potenti
endem
pandem
pathogen
genom
studi
allud
complex
ecosystem
interact
compon
biospher
increasingli
genom
engag
transdisciplinari
studi
involv
expert
clinic
epidemiolog
anthropolog
ecolog
veterinari
field
identifi
risk
solut
mani
host
unaffect
pathogen
harbor
pathogen
often
affect
close
relat
speci
human
be
great
ape
mani
endem
pathogen
hiv
origin
primat
influenza
coronavirus
like
sar
middl
east
respiratori
syndrom
anim
reservoir
host
genom
studi
promis
approach
pandem
plan
respons
map
origin
suscept
thought
ecolog
genom
also
impact
environment
anim
plant
scienc
techniqu
mention
enabl
creation
genet
modifi
organ
adapt
anthropocentr
climat
chang
improv
food
sustain
diseas
protect
nutrit
valu
well
produc
chemic
drug
use
human
be
gene
edit
base
crispr
promis
novel
organ
adapt
extrem
environ
novel
function
water
purif
pollut
cleanup
clinic
signific
public
health
genom
grow
sequenc
becom
possibl
low
error
rate
use
better
analyt
method
signal
variant
clinic
signific
develop
technolog
allow
longterm
stabil
data
storag
exampl
comprehens
analysi
genom
sequenc
individu
cancer
help
uncov
specif
mutat
contribut
malign
phenotyp
identif
new
target
therapi
increas
opportun
choos
optim
treatment
patient
impact
cancer
genom
across
popul
would
substanti
present
like
infrastructur
place
support
patient
physician
encount
result
data
moreov
even
promis
technolog
fulli
realiz
potenti
relev
polici
legal
regulatori
issu
adequ
address
